Literature DB >> 795384

Absence of leukocyte-migration inhibitory factor in serum from patients with mycosis fungoides.

H Thulin.   

Abstract

Sera from 16 patients with mycosis fungoides at various stages of the disease were investigated for the presence of a leukocyte-migration inhibitory factor. The agarose gel techinque with human peripheral blood leukocytes as migrating indicator cells was used for the purpose. The migration inhibitory effect of patients sera, pooled AB-sera and sera from control persons was tested on peripheral blood leukocytes from patients and controls. Also upconcentrated sera were used. The presence of substances with migration inhibitory effect in serum from patients with mycosis fungoides could not be demonstrated. The significance of these findings is discussed.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 795384     DOI: 10.1007/bf00558089

Source DB:  PubMed          Journal:  Arch Dermatol Res            Impact factor:   3.017


  14 in total

1.  Migration inhibitory activity in serum and cell supernatants in patients with Sezary syndrome.

Authors:  T Yoshida; R Edelson; S Cohen; I Green
Journal:  J Immunol       Date:  1975-03       Impact factor: 5.422

2.  Serum migration-inhibitory activity in patients with lymphoproliferative diseases.

Authors:  S Cohen; B Fisher; T Yoshida; R E Bettigole
Journal:  N Engl J Med       Date:  1974-04-18       Impact factor: 91.245

3.  Complete remissions of mycosis fungoides lymphoma induced by topical nitrogen mustard (HN2). Control of delayed hypersensitivity to HN2 by desensitization and by induction of specific immunologic tolerance.

Authors:  E J Van Scott; J D Kalmanson
Journal:  Cancer       Date:  1973-07       Impact factor: 6.860

4.  Properties of the Sezary lymphoid cell. An ultrastructural analysis.

Authors:  D Zucker-Franklin
Journal:  Mayo Clin Proc       Date:  1974-08       Impact factor: 7.616

5.  The Sezary cell: cytologic, cytochemical, and immunologic studies.

Authors:  G Flandrin; J C Brouet
Journal:  Mayo Clin Proc       Date:  1974-08       Impact factor: 7.616

6.  Morphologic and functional properties of the atypical T lymphocytes of the Sezary syndrome.

Authors:  R L Edelson; M A Lutzner; C H Kirkpatrick; E M Shevach; I Green
Journal:  Mayo Clin Proc       Date:  1974-08       Impact factor: 7.616

7.  Migration inhibitory effect of cell-free supernatants from tuberculin-stimulated cultures of human mononuclear leukocytes demonstrated by two-step MIF agarose assay.

Authors:  J E Clausen
Journal:  J Immunol       Date:  1973-02       Impact factor: 5.422

8.  Macrophage migration inhibition by serum from desensitized animals previously sensitized with tubercle bacilli.

Authors:  K Yamamoto; Y Takahashi
Journal:  Nat New Biol       Date:  1971-10-27

9.  An in vitro assay of leukocyte migration inhibitory activity from human lymphocytes stimulated with concanavalin A.

Authors:  K Bendtzen; V Andersen; G Bendixen
Journal:  Acta Allergol       Date:  1975-07

10.  Migration inhibitory factor and interferon in the circulation of mice with delayed hypersensitivity.

Authors:  S B Salvin; J S Youngner; W H Lederer
Journal:  Infect Immun       Date:  1973-01       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.